Unaudited Results to 30 June 2023
Shares In Issue
The number of ordinary shares of the Company in issue is 121,666,666, with approximately 56% deemed to be in public hands.
The Company has been notified of the following interests of 5% or more in the issued ordinary share capital of the Company
|Number||Ordinary Shares %|
|Seneca Partners Limited||8,025,450||6.60%|
|Number||Ordinary Share %|
Restrictions on transfer of the Company's Securities
There are no restrictions on the transfer of ProBiotix Health plc's Aquis Exchange securities.
UK City Code on Takeovers and Mergers
ProBiotix Health plc is subject to the UK City Code on Takeovers and Mergers.
Other exchanges and trading platforms
ProBiotix Health plc has not applied or agreed to have any of it securities (including its Aquis Exchange securities) admitted or traded on any other exchanges or trading platforms.
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments
Stephen O'Hara | 23 February 2023
IG UK | Youtube